Records containing: Invasive Candidiasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-17Short Course Versus Standard Course Antifungal Therapy for Uncomplicated Candidemia in Children and Adolescents: A Multi-Center Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (The ReSPECT Study)
-
CLINICAL_TRIALS study record update · 2026-02-19The Importance of Non-Conventional Microbiological Methods in the Diagnosis of Candidemia and the Host Cytokine Response to Different Fungal Pathogens
-
CLINICAL_TRIALS study record update · 2025-11-21Pharmacokinetics of Micafungin in Patients of Intensive Care Units
-
CLINICAL_TRIALS study record update · 2025-06-05Invasive Candidiasis in Critical Care
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-09An Open Clinical Trial to Evaluate the Safety, Efficacy and Population Pharmacokinetics of Amphotericin B Cholesteryl Sulfate Complex for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus
-
CLINICAL_TRIALS study record update · 2024-11-20Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)
-
CLINICAL_TRIALS study record update · 2024-11-18A Phase 1, Open-Label Study Of The Safety And Pharmacokinetics Of Repeated-Dose Micafungin (FK463) In Children (2-5 Years AND 6-11 Years) And Adolescents (12-16 Years) With Esophageal Candidiasis Or Other Invasive Candidiasis
-
CLINICAL_TRIALS study record update · 2024-05-16Impact of the Use of Biomarkers on Early Discontinuation of Empirical Antifungal Therapy in Critically Ill Patients: a Randomized Controlled Study.
-
CLINICAL_TRIALS study record update · 2022-08-11A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Micafungin (50 mg/Vial) After Intravenous Infusion of 50 mg Micafungin in Healthy Volunteers Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2022-02-28Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric
-
CLINICAL_TRIALS study record update · 2021-09-22NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis
-
CLINICAL_TRIALS study record update · 2021-04-12Multicenter Study to Compare Two Diagnostic Tests (1,3-β-D-glucan vs Blood Culture) in Critically Ill Patients With Suspected Invasive CAndidiasis Hospitalized in Internal Medicine Wards and Who Are Currently Timely Treated With Echinocandin (Micafungin)
-
CLINICAL_TRIALS study record update · 2021-03-26Genetic Susceptibility Factors Involved in Candidemia: Case-control Study.
-
CLINICAL_TRIALS study record update · 2020-12-08A Phase 2, Multicenter, Randomized, Double-blind Study of the Safety, Tolerability, and Efficacy of Intravenous CD101 vs Intravenous Caspofungin Followed by Oral Fluconazole Step-down in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
-
CLINICAL_TRIALS study record update · 2020-01-13An Open, Multicenter Clinical Study to Evaluate the Safety, Efficacy, and Population Pharmacokinetics of ABCD for Invasive Candidiasis and Invasive Aspergillosis
-
CLINICAL_TRIALS study record update · 2019-11-05Safety and Pharmacokinetics of Micafungin in Children Supported With Extracorporeal Membrane Oxygenation
-
CLINICAL_TRIALS study record update · 2018-08-24Invasive Candidiasis in Critically Ill Patients in Saudi Arabia: A Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2017-05-03Fluconazole Exposure in Critically Ill Patients and the Value of Therapeutic Drug Monitoring
-
CLINICAL_TRIALS study record update · 2017-01-12Pharmacokinetics of Micafungin in Critically Ill Patients With Invasive Candidiasis
-
CLINICAL_TRIALS study record update · 2016-02-04Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins
-
CLINICAL_TRIALS study record update · 2015-04-03Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?
-
CLINICAL_TRIALS study record update · 2015-03-24Micafungin Versus Placebo in the Nosocomial Sepsis in Patients Multi-colonized With Candida, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2014-08-20A Phase 1, Open-Label Study Of The Safety And Pharmacokinetics Of Repeated-Dose Micafungin (FK463) In Infants And Toddlers (≥4 Months TO < 24 Months Of Age) With Esophageal Candidiasis Or Other Invasive Candidiasis
-
CLINICAL_TRIALS study record update · 2013-05-10MSG-04 (Also Known as Merck Caspofungin Protocol 067): A Pilot, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Empirical Therapy for Invasive Candidiasis in High-Risk Patients in the Critical Care Setting